Pathstone Holdings’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
67,092
-3,204
| -5% | -$53.7K | ﹤0.01% | 1327 |
|
|
2025
Q1 | $1.08M | Sell |
70,296
-4,357
| -6% | -$67K | ﹤0.01% | 1337 |
|
|
2024
Q4 | $1.65M | Buy |
74,653
+2,055
| +3% | +$45.3K | 0.01% | 1083 |
|
|
2024
Q3 | $1.31M | Buy |
72,598
+4,452
| +7% | +$80.2K | 0.01% | 1220 |
|
|
2024
Q2 | $1.11M | Buy |
68,146
+4,932
| +8% | +$80.1K | 0.01% | 1269 |
|
|
2024
Q1 | $892K | Buy |
63,214
+19,285
| +44% | +$272K | ﹤0.01% | 1347 |
|
|
2023
Q4 | $459K | Buy |
+43,929
| New | +$459K | ﹤0.01% | 1561 |
|